Literature DB >> 20871215

Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Nobuyuki Ohike1, Ipek Coban, Grace E Kim, Olca Basturk, Takuma Tajiri, Alyssa Krasinskas, Sudeshna Bandyopadhyay, Toshio Morohoshi, Yuki Shimada, David A Kooby, Charles A Staley, Michael Goodman, N Volkan Adsay, Nazmi Volkan Adsay.   

Abstract

Prognostication of invasive ampullary adenocarcinomas (AACs) and their stratification into appropriate management categories have been highly challenging owing to a lack of well-established predictive parameters. In colorectal cancers, recent studies have shown that tumor budding confers a worse prognosis and correlates significantly with nodal metastasis and recurrence; however, this has not been evaluated in AAC.To investigate the prevalence, significance, and clinical correlations of tumor budding in AAC, 244 surgically resected, stringently defined, invasive AAC were analyzed for tumor budding---defined as the presence of more than or equal to 5 isolated single cancer cells or clusters composed of fewer than 5 cancer cells per field measuring 0.785 mm using a 20× objective lens in the stroma of the invasive front. The extent of the budding was then further classified as "high" if there were greater than or equal to 3 budding foci and as "low" if there were <3 budding foci or no budding focus.One hundred ninety-four AACs (80%) were found to be high-budding and 50 (20%) were low-budding. When the clinicopathologic features and survival of the 2 groups were compared, the AACs with high-budding had larger invasion size (19 mm vs. 13 mm; P<0.001), an unrecognizable/absent preinvasive component (57% vs. 82%; P<0.005), infiltrative growth (51% vs. 2%; P<0.001), nonintestinal-type histology (72% vs. 46%; P<0.001), worse differentiation (58% vs. 10%; P<0.001), more lymphatic (74% vs. 10%; P<0.001), and perineural invasion (28% vs. 2%; P<0.001); more lymph node metastasis (44% vs. 17%; P<0.001), higher T-stage (T3 and T4) (42% vs. 10%; P<0.001), and more aggressive behavior (mean survival: 50 mo vs. 32 mo; 3-year and 5-year survival rates: 93% vs. 41% and 68% vs. 24%, respectively; P<0.001). Furthermore, using a multivariable Cox regression model, tumor budding was found to be an independent predictor of survival (P=0.01), which impacts prognosis (hazard ratio: 2.6) even more than T-stage and lymph node metastasis (hazard ratio: 1.9 and 1.8, respectively).In conclusion, tumor budding is frequently encountered in AAC. High-budding is a strong independent predictor of overall survival, with a prognostic correlation stronger than the 2 established parameters: T-stage and lymph node metastasis. Therefore, budding should be incorporated into surgical pathology reports for AAC.

Entities:  

Mesh:

Year:  2010        PMID: 20871215      PMCID: PMC3163902          DOI: 10.1097/PAS.0b013e3181f0b05a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  52 in total

1.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

2.  Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.

Authors:  Sang Myung Woo; Ji Kon Ryu; Sang Hyub Lee; Ji Won Yoo; Joo Kyung Park; Yong-Tae Kim; Jin-Young Jang; Sun-Whe Kim; Gyeong Hoon Kang; Yong Bum Yoon
Journal:  Ann Surg Oncol       Date:  2007-08-19       Impact factor: 5.344

3.  The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.

Authors:  Young-Hoon Roh; Young-Hoon Kim; Hyoun-Wook Lee; Su-Jin Kim; Mee-Sook Roh; Jin-Sook Jeong; Ghap-Joong Jung
Journal:  Hepatogastroenterology       Date:  2007-09

4.  Tumour budding at invasive margins and outcome in colorectal cancer.

Authors:  H Kanazawa; H Mitomi; Y Nishiyama; I Kishimoto; N Fukui; T Nakamura; M Watanabe
Journal:  Colorectal Dis       Date:  2008-01       Impact factor: 3.788

5.  Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.

Authors:  Hiroshi Miyata; Akiko Yoshioka; Makoto Yamasaki; Yoichiro Nushijima; Shuji Takiguchi; Yoshiyuki Fujiwara; Toshiro Nishida; Masayuki Mano; Masaki Mori; Yuichiro Doki
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

6.  Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor.

Authors:  Masahiko Koike; Yasuhiro Kodera; Yuichi Itoh; Goro Nakayama; Michitaka Fujiwara; Nobuyuki Hamajima; Akimasa Nakao
Journal:  Ann Surg Oncol       Date:  2008-04-12       Impact factor: 5.344

7.  The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.

Authors:  Yoshiaki Shimizu; Fumihiko Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Masayuki Ohtsuka; Masaru Miyazaki
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

8.  Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.

Authors:  Lai Mun Wang; David Kevans; Hugh Mulcahy; Jacintha O'Sullivan; David Fennelly; John Hyland; Diarmuid O'Donoghue; Kieran Sheahan
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

9.  Tumors of the ampulla of vater: histopathologic classification and predictors of survival.

Authors:  Jonathan T Carter; James P Grenert; Laura Rubenstein; Lygia Stewart; Lawrence W Way
Journal:  J Am Coll Surg       Date:  2008-05-05       Impact factor: 6.113

10.  Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.

Authors:  Petra Ruemmele; Wolfgang Dietmaier; Luigi Terracciano; Luigi Tornillo; Frauke Bataille; Annette Kaiser; Peter-Heinz Wuensch; Ernst Heinmoeller; Kia Homayounfar; Jutta Luettges; Guenter Kloeppel; Fausto Sessa; Tina Bocker Edmonston; Regine Schneider-Stock; Monika Klinkhammer-Schalke; Armin Pauer; Stefan Schick; Ferdinand Hofstaedter; Daniel Baumhoer; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

View more
  30 in total

Review 1.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  Analysis of Endoscopy Findings to Identify Early Gastric Cancers with Tumor Budding: A Retrospective Study.

Authors:  Lanqing Cao; Zhaoyong Wang; Liwei Duan; Lijuan Wei
Journal:  J Gastrointest Surg       Date:  2020-11-09       Impact factor: 3.452

3.  Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Authors:  Cheng Wang; Hongzhang Huang; Zhiquan Huang; Anxun Wang; Xiaohua Chen; Lei Huang; Xiaofeng Zhou; Xiqiang Liu
Journal:  J Oral Pathol Med       Date:  2011-04-12       Impact factor: 4.253

4.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

5.  Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.

Authors:  Michelle D Reid; Serdar Balci; Nobuyuki Ohike; Yue Xue; Grace E Kim; Takuma Tajiri; Bahar Memis; Ipek Coban; Anil Dolgun; Alyssa M Krasinskas; Olca Basturk; David A Kooby; Juan M Sarmiento; Shishir K Maithel; Bassel F El-Rayes; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

6.  Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?

Authors:  Fabio Grizzi; Giuseppe Celesti; Gianluca Basso; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 7.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

8.  A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma.

Authors:  Christina L Roland; Matthew H G Katz; Graciela M N Gonzalez; Peter W T Pisters; Jean-Nicolas Vauthey; Robert A Wolff; Christopher H Crane; Jeffrey E Lee; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2012-08-23       Impact factor: 3.452

9.  Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.

Authors:  Iván González; Philip S Bauer; William C Chapman; Zahra Alipour; Rehan Rais; Jingxia Liu; Deyali Chatterjee
Journal:  Ann Diagn Pathol       Date:  2019-12-14       Impact factor: 2.090

Review 10.  Primary small bowel adenomas and adenocarcinomas-recent advances.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  Virchows Arch       Date:  2018-07-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.